Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Pluri Inc. PLUR
$0.87
-$0.02 (-2.02%)
На 17:51, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
33904172.00000000
-
week52high
1.66
-
week52low
0.65
-
Revenue
234000
-
P/E TTM
-1
-
Beta
1.58719700
-
EPS
-1.00000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 04:00
Описание компании
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| YANAY YAKY | A | 500000 | 500000 | 22 дек 2022 г. |
| YANAY YAKY | A | 334821 | 334821 | 22 дек 2022 г. |
| YANAY YAKY | A | 1760125 | 334821 | 22 дек 2022 г. |
| Aberman Zami | D | 1491973 | 2000 | 20 дек 2022 г. |
| Aberman Zami | A | 91756 | 80616 | 10 февр 2022 г. |
| Birger Pinhas Doron | A | 20000 | 20000 | 15 июл 2021 г. |
| Shalev Varda | A | 20000 | 20000 | 15 июл 2021 г. |
| CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | D | 3121918 | 45000 | 28 мая 2021 г. |
| CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | D | 3166918 | 70007 | 28 мая 2021 г. |
| CLOVER WOLF CAPITAL - LIMITED PARTNERSHIP | D | 3236925 | 24110 | 27 мая 2021 г. |
Новостная лента
Pluri to Present and Participate in Upcoming Conferences
GlobeNewsWire
31 окт 2022 г. в 08:00
HAIFA, Israel, Oct. 31, 2022 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”)(formerly known as Pluristem Therapeutics, Inc.), a leading biotechnology company, today announced its participation in three upcoming conferences.
Pluristem (PSTI) Phase III Study Misses Goal, Stock Down
Zacks Investment Research
14 июл 2022 г. в 12:24
Pluristem (PSTI) phase III study of muscle regeneration following hip fracture surgery evaluating PLX-PAD cells did not meet the primary endpoint. Consequently, the stock declines.
Pluristem Posts Mixed Results From Study Of Muscle Regeneration After Hip Fracture Surgery
Benzinga
13 июл 2022 г. в 09:59
Pluristem Therapeutics Inc (NASDAQ: PSTI) announced topline results from its Phase 3 study of intramuscular administration of allogeneic PLX-PAD cells for muscle injury following arthroplasty for hip fracture. The 240-subject study did not meet the primary endpoint, the Short.
Best Penny Stocks to Buy as January Ends? 4 to Watch
PennyStocks
22 янв 2022 г. в 11:30
Here are four penny stocks to add to your end of January watchlist The post Best Penny Stocks to Buy as January Ends? 4 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Best Penny Stocks to Buy Right Now? 3 For Your List in January
PennyStocks
10 янв 2022 г. в 10:38
Check these three penny stocks out for your January watchlist The post Best Penny Stocks to Buy Right Now? 3 For Your List in January appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.